프랑스의 초음파 장치 시장 : 점유율 분석, 산업 동향, 성장 예측(2025-2030년)

The France Ultrasound Devices Market size is estimated at USD 501.65 million in 2025, and is expected to reach USD 658.13 million by 2030, at a CAGR of 5.58% during the forecast period (2025-2030).

The pandemic had an adverse effect on the ultrasound devices market in the country. Additionally, the well-known for its effectiveness French healthcare system was put under a great deal of stress in the early phases of the pandemic. Portable ultrasound machines are essential in the fight against the COVID-19 pandemic, according to a research paper that appeared in the Springer Journal in February 2020. In France, intensive care physicians use point-of-care ultrasounds, typically with small transportable ultrasound devices, for bedside imaging, and in the ICU. Although there was a decrease in the overall number of ultrasounds in private centers as a result of COVID-19, this was because 52.8% of the radiologic structures followed the French recommendations to dedicate devices to COVID-19, which led to fewer ultrasound devices and more COVID-19 patients, which in turn limited access for other pathologies. According to the article "Effect of the COVID-19 Pandemic on Colorectal Cancer Care in France" published in the Lancet magazine in May 2021, researchers found a 31% decrease in new referrals for colorectal cancer in 2020 (March to May) compared to the average of the preceding two years. On the other hand, the epidemic has moved attention away from cancer treatment. Because fewer people were screened within the nation as a result, fewer ultrasound scans were performed nationwide. Thus, the market had an adverse effect during the pandemic however, it is expected to grow as pending cases will boost the market in the upcoming period.

The ultrasound market in France is expected to grow during the study's forecast period due to the rising prevalence of chronic diseases such as cardiovascular diseases, as well as technical advances in the country. For instance, according to a report titled "Heart Failure Policy and Practice in Europe: France" that was released in November 2020, heart failure is predicted to impact approximately one million people in France or 2.3% of the country's total population. Heart attacks are significantly increased by coronary artery disease and other cardiovascular disease risk factors like diabetes and hypertension. Ultrasound imaging devices are one of the most crucial diagnostic imaging systems for the diagnosis of a variety of cardiovascular abnormalities, including coronary artery disease. Major players are engaged in a variety of strategic activities. These include of product launches, collaborations, partnerships, mergers, and acquisitions. For instance, to speed up the development of AI in medical imaging, the AI DReAM initiative, coordinated by GE Healthcare, will bring together French SMEs, start-ups, research labs, and clinical centers in September 2020. The "Investments for the Future" program (PIA), which is run by Bpifrance and is overseen by the French General Secretariat for Investment, provided funding for the AI DReAM project. It strives to increase the effectiveness of the healthcare system, patient care pathways, and diagnosis accuracy. Thus, the abovementioned factors are expected to increase market growth.

France Ultrasound Devices Market Trends

High-intensity Focused Ultrasound Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Focused ultrasonic energy can be utilized to treat a variety of solid tumours because it is a non-invasive approach for tissue ablation. High-intensity focused ultrasound is being utilised more frequently to treat both primary and metastatic tumours because it can accurately identify tumours for ablation. Factors such as increasing cancer prevalence and initiatives by key players are expected to increase the market growth. In 2020, France recorded 467,965 new cancer cases, while there were 1,501,881 new cases of cancer overall. Globocan 2020 predicted that by 2040, there will be roughly 579,388 new cancer cases in France. Increased use of high-intensity focused ultrasound systems for the diagnosis will result from the country's increasing number of new cancer cases, which is anticipated to propel this market's expansion in France over the course of the projected period.

High-intensity ultrasound products from several major market players are being introduced in France, which will increase the use of HIFU systems. For instance, THERACLION, a forward-thinking French company that specializes in echotherapy (using HIFU or High-Intensity Focused Ultrasound) treatment, received the CE Mark for the second generation of SONOVEIN, its HIFU varicose vein treatment option, in October 2020. Increased acceptance of HIFU systems in this region is anticipated to fuel the growth of this market in France as a result of the key players' increasing initiatives by releasing their products in the treatment of varicose veins to provide patients access to non-invasive varicose vein treatments. Future market expansion is anticipated to be fueled by rising research activities on high-intensity ultrasound systems for the treatment of various illnesses as well as approvals from the French health authorities. For instance, in August 2020, EDAP TMS SA will launch a Phase II multicenter clinical trial evaluating its Focal One HIFU for the management of deep rectal endometriosis with permission from the French Ministry of Health. This Phase II multicenter trial will assess safety and efficacy in a single patient group of 38 women with a confirmed diagnosis of deep rectal endometriosis in a total of five major French hospitals. This will lead to increased research activities on HIFU systems for different ailments and result in the adoption of HIFU systems for different diseases, thereby expected to drive the market growth in France.

Hence, the above developments pertaining to high-intensity focused ultrasound systems, it is expected to drive market growth in the country.

France Ultrasound Devices Industry Overview

France ultrasound devices market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Canon Medical Systems Corporation, GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, and Koninklijke Philips NV among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Chronic Diseases
  • 4.2.2 Technological Advancements
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulations
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

• 5.1 By Application
  • 5.1.1 Anesthesiology
  • 5.1.2 Cardiology
  • 5.1.3 Gynecology/Obstetrics
  • 5.1.4 Musculoskeletal
  • 5.1.5 Radiology
  • 5.1.6 Critical Care
  • 5.1.7 Other Applications
• 5.2 By Technology
  • 5.2.1 2D Ultrasound Imaging
  • 5.2.2 3D and 4D Ultrasound Imaging
  • 5.2.3 Doppler Imaging
  • 5.2.4 High-intensity Focused Ultrasound
• 5.3 By Type
  • 5.3.1 Stationary Ultrasound
  • 5.3.2 Portable Ultrasound

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Canon Medical Systems Corporation
  • 6.1.2 SonoScape Medical Corp
  • 6.1.3 Fujifilm Holdings Corporation
  • 6.1.4 GE Healthcare
  • 6.1.5 Hologic Inc.
  • 6.1.6 Koninklijke Philips NV
  • 6.1.7 Mindray Medical International Limited
  • 6.1.8 Samsung Electronics Co. Ltd
  • 6.1.9 Esaote SpA
  • 6.1.10 Siemens Healthineers AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS